Fu-sheng Wan

Dr. Fu-sheng Wan

Department of Biochemistry and Molecular Biology, Basic Medical College of Nanchang University

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2014 in Acta Biochimica et Biophysica Sinica
Verified
Journal Article
Open access
PDF file
XZXiali Zhang
Xiali Zhang
STShuo Tu
Shuo Tu
YWYibing Wang
Yibing Wang
BXBaohua Xu
Baohua Xu
FWFu-sheng Wan
Fu-sheng Wan
Taurine (Tau) has been shown to possess cancer therapeutic effect through induction of apoptosis, while the underlying molecular mechanism of its anti-cancer effect is not well understood. PUMA (p53-upregulated modulator of apoptosis) plays an important role in the process of apoptosis induction in a variety of human tumor cells in both p53-dependent and -independent manners. However, whether PUMA is involved in the process of Tau-induced apoptosis in cancer cells has not been well studied. In the present study, we treated human colorectal cancer cells HT-29 (mutant p53) and LoVo (wild-type p53) with different concentrations of Tau, which led to the repression of cell proliferation and induction of apoptosis in both cell lines. Meanwhile, we also observed the increased expression of PUMA and high Bax/Bcl-2 ratios. To determine the role of PUMA in Tau-induced apoptosis, we used small interfering RNA interference to suppress PUMA expression. As a result, apoptosis was decreased in response to Tau treatment. All these results indicated that PUMA plays a critical role in Tau-induced apoptosis pathway in human colorectal cancer cells. Demonstration of the molecular mechanism involved in the anti-tumor effect of Tau may be useful in the therapeutic target selection for p53-deficient colorectal cancer.

10 September 2019 in Oncology Letters
Verified
Journal Article
Open access
PDF file
HZHui Zhou
Hui Zhou
LSLina Sun
Lina Sun
FWFu-sheng Wan
Fu-sheng Wan
Long non‑coding RNAs (lncRNAs) are RNA sequences >200 nucleotides in length that have no protein‑coding capacity. lncRNAs serve key roles in multiple biological processes, such as tumorigenesis and tumor progression. Taurine upregulated 1 (TUG1) is a novel lncRNA that has been associated with human cancer. TUG1 has attracted increasing attention in recent years and has been documented to be abnormally expressed in different types of cancer. Numerous studies indicate that TUG1 may be significantly associated with tumor development and cell metabolism by regulating cell proliferation, invasion, metastasis, apoptosis, differentiation and drug resistance. TUG1 exerts its function via recruiting specific RNA‑binding proteins, promoting target gene expression, influencing tumor angiogenesis and by functioning as a competing endogenous RNA (ceRNA). An increasing number of studies have demonstrated that ceRNAs serve a role in cancer development. TUG1 is considered to be a biomarker or a novel therapeutic target for the diagnosis and prognosis of different cancer types. The present review focuses on recent developments in the major underlying molecular mechanisms of TUG1 in cancer, including its role in cell proliferation, apoptosis, migration, invasion and drug resistance. Also discussed in the present review is the current knowledge regarding the regulation of TUG1.

11 June 2014 in International Journal of Molecular Medicine
Verified
Journal Article
Open access
PDF file
WLWeiwei Liu
Weiwei Liu
CXChuanming Xu
Chuanming Xu
HWHuifang Wan
Huifang Wan
CLChunju Liu
Chunju Liu
CWCan Wen
Can Wen
FWFu-sheng Wan
Fu-sheng Wan
MicroRNA-206 (miR-206) is known to regulate cell proliferation and migration and is involved in various types of cancer. However, the role of miR-206 in human hepatocellular carcinoma (HHC) has not been previously reported. In the present study, the expression of Notch3 in HCC and adjacent non-neoplastic tissue was immunohistochemically assessed on formalin-fixed, paraffin-embedded sections. miR-206 mimics were transiently transfected into HepG2 cells using Lipofectamine™ 2000. Subsequently, we evaluated the role of miR-206 in cell proliferation, apoptosis, cell cycle arrest and migration by MTS assay, Hoechst 33342 staining, Annexin V-FITC/PI assay, flow cytometry and wound healing assay. Using quantitative reverse transcription polymerase chain reaction (qRT‑PCR) and western blot analysis, we detected the expression of Notch3, Bax, Bcl-2, Hes1, p57 and matrix metalloproteinase (MMP)-9 at the mRNA and protein level, respectively. In addition, we measured the expression of miR-206 at the mRNA level and that of caspase-3 at the protein level. After miR-206 was upregulated in HepG2 cells, Notch3, Hes1, Bcl-2 and MMP-9 were downregulated both at the mRNA and protein level, whereas p57 and Bax were upregulated. Cleaved caspase-3 protein expression was also markedly increased. Cell proliferation was significantly attenuated and apoptosis was markedly increased. Furthermore, miR-206 overexpression induced cell cycle arrest and inhibited the migration of HepG2 cells. Taken together, our results uggest that miR-206 is a potential regulator of apoptosis, the cell cycle and migration in HepG2 cells and that it has the potential for use in the targeted therapy of HCC and is a novel tumor suppressor.

20 April 2019 in Chinese Medical Journal
Verified
Journal Article
Open access
HLHua Li
Hua Li
WRWen-Jing Ruan
Wen-Jing Ruan
LLLi-Qiao Liu
Li-Qiao Liu
HWHui-Fang Wan
Hui-Fang Wan
XYXiao-Hong Yang
Xiao-Hong Yang
FWFu-sheng Wan
Fu-sheng Wan
Cervical cancer has the fourth highest incidence and mortality rate of all cancers in women worldwide; it seriously harms their physical and mental health. The aim of this study was to observe the roles and preliminary mechanism of Taurine (Tau)-induced apoptosis in cervical cancer cells. Cells from the human cervical cancer cell line SiHa were transfected with the recombinant plasmid pEGFP-N1-MST1 (mammalian sterile 20-like kinase 1); then, the cell proliferation activity was analyzed by the MTT assay, cell apoptosis, by flow cytometry, and the related protein levels, by Western blotting. Tau inhibited the proliferation of SiHa cells and induced apoptosis in these cells (The apoptotic rate was 21.95% in the Tau 160 mM group and 30% in the Tau 320 mM group), upregulated the expression of the MST1 (control, 0.53; Tau 40–320 mM groups, 0.84–1.45) and Bax (control, 0.45; Tau 40–320 mM groups, 0.64–1.51) proteins (P < 0.01), and downregulated the expression of Bcl-2 (control, 1.28, Tau 40–320 mM groups, 0.93–0.47) (P < 0.01). The overexpression of MST1 promoted the apoptosis of SiHa cells, enhanced the apoptosis-inductive effects of Tau (P < 0.01), upregulated the expression of the proapoptotic proteins p73, p53, PUMA (p53 upregulated modulator of apoptosis), and caspase-3, and promoted the phosphorylation of YAP (Yes-associated protein). Tau inhibited the proliferation and induced the apoptosis of cervical cancer SiHa cells. The MST1 protein plays an important role in the Tau-induced apoptosis of cervical cancer cells. Thisis an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0

1 January 2018 in Journal of Breast Cancer
Verified
Journal Article
Open access
PDF file
CHChang-Chang Han
Chang-Chang Han
FWFu-sheng Wan
Fu-sheng Wan
Han CC, et al. J Breast Cancer. 2018 Oct;21:e51. https://doi.org/10.4048/jbc.2018.21.e51

1 January 2018 in Libyan Journal of Medicine
Verified
Journal Article
Open access
ZLZhuoqi Liu
Zhuoqi Liu
YXYanqin Xia
Yanqin Xia
XZXiali Zhang
Xiali Zhang
LLLiqiao Liu
Liqiao Liu
STShuo Tu
Shuo Tu
FWFu-sheng Wan
Fu-sheng Wan
The aim of this study was to observe the impact of the mammalian sterile 20-like kinase 1-c-Jun N-terminal kinase (MST1-JNK) signaling pathway on apoptosis in colorectal cancer (CRC) cells induced by Taurine (Tau). Caco-2 and SW620 cells transfected with p-enhanced green fluorescent protein (EGFP)-MST1 or short interfering RNA (siRNA)-MST1 were treated with Tau for 48 h. Apoptosis was detected by flow cytometry, and the levels of MST1 and JNK were detected by western blotting. Compared with the control group, 80 mM Tau could significantly induce apoptosis of CRC cells, and the apoptotic rate increased with increasing Tau concentration (P < 0.01). Meanwhile, the protein levels of MST1 and phosphorylated (p)-JNK in Caco-2 cells increased significantly (P < 0.01). The apoptotic rate of the p-EGFP-MST1 plasmid-transfected cancer cells was significantly higher than that of the control group (P < 0.05); however, the apoptotic rate of the p-EGFP-MST1+Tau group was increased further (P < 0.01). Silencing the MST1 gene could decrease the apoptotic rate of cancer cells, and Tau treatment could reverse this decrease. Blocking the JNK signaling pathway significantly reduced the Tau-induced apoptotic rate of CRC cells. Thus, the MST1-JNK pathway plays an important role in Tau-induced apoptosis of CRC cells.